CIBC Bancorp USA’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Other funds holding CYTK
CIBC Bancorp USA's CYTK Position: Q3 2026 in Review
CIBC Bancorp USA increased its Cytokinetics (CYTK) stake by 53% in Q3 2026, buying an estimated $462K and bringing the position to 17,523 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #1075.
CIBC Bancorp USA first reported a position in CYTK in Q3 2025 and has held it in 4 quarters since. 468 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.
- CIBC Bancorp USA held 17,523 shares of Cytokinetics worth $1.15M as of Q3 2026.
- CIBC Bancorp USA bought 6,062 Cytokinetics shares in Q3 2026, an estimated $462K.
- Cytokinetics made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #1075 holding.
- CIBC Bancorp USA first reported a position in Cytokinetics in Q3 2025 and has held it in 4 quarters since.
- 468 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.
Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.